Summary
Boston Scientific Corporation (BSX) filed an 8-K on April 25, 2018, to report its first quarter financial results ended March 31, 2018. The filing primarily serves to furnish a press release (Exhibit 99.1) detailing these results. Investors should refer to the press release for specific financial performance metrics and operational updates for the quarter. This report signifies the official disclosure of the company's performance during the period and provides the basis for subsequent investor analysis and guidance discussions. While the 8-K itself does not contain the detailed financial tables or commentary, it is the official vehicle through which the company made its Q1 2018 results public. The furnished press release is expected to cover key aspects such as revenue, earnings per share (EPS), and potentially segment performance. It's important to note that the information furnished under Item 2.02 is generally not considered 'filed' for liability purposes under the Securities Exchange Act, but it remains a critical source of information for understanding the company's recent financial standing.
Key Highlights
- 1Boston Scientific (BSX) filed an 8-K on April 25, 2018, to report its Q1 2018 financial results.
- 2The filing primarily furnishes a press release (Exhibit 99.1) containing the Q1 2018 financial results.
- 3Investors should consult the furnished press release for detailed financial performance, including revenue and EPS.
- 4The report covers the financial performance for the quarter ended March 31, 2018.
- 5Information furnished under Item 2.02 is not deemed 'filed' for certain liabilities under the Exchange Act.